Search results: "University" (Page 1 of 27)

Bench2Market Talks: Opportunities through CROs

As an academic innovator and entrepreneur, you can’t do everything. Contract research organizations can extend your startup’s capabilities and speed up the development of your biomedical innovations. Hear from three CROs and one Academic Innovator who has worked extensively with CROs. CROs on the panel will include Marta New, Founder and CEO at Radyus Research, Kalpana Raman, Director of Business Development at Veranex, and Evan Goldberg, Director of Scientific Affairs at Global Center for Medical Innovation. Also on the panel is Dr. Eric Miller, Assistant Professor at Emory School of Medicine, with extensive anti-viral drug development experience.
 
 
This is the eighth session in the 2023-2024 Bench2Market Talks series, created to provide commercialization guidance to the university research community. For more details, visit https://biolocity.gatech.edu/bench2market/.

Bench2Market Talks: Opportunties through CROs

As an academic innovator and entrepreneur, you can’t do everything. Contract research organizations can extend your startup’s capabilities and speed up the development of your biomedical innovations. Hear from three CROs and one Academic Innovator who has worked extensively with CROs. CROs on the panel will include Marta New, Founder and CEO at Radyus Research, Kalpana Raman, Director of Business Development at Veranex, and Evan Goldberg, Director of Scientific Affairs at Global Center for Medical Innovation. Also on the panel is Dr. Eric Miller, Assistant Professor at Emory School of Medicine, with extensive anti-viral drug development experience.
 
 
This is the eighth session in the 2023-2024 Bench2Market Talks series, created to provide commercialization guidance to the university research community. For more details, visit https://biolocity.gatech.edu/bench2market/.

Biolocity is a philanthropic, multi-institutional program supporting and accelerating the commercialization of early-stage medical technologies with intellectual property held at Emory University and/or Georgia Institute of Technology.

The Biolocity approach encompasses:
Biolocity U – Educational resources focusing on life science commercialization are provided for faculty, students, post-doctoral trainees, and members of the community through the below opportunities.

Biolocity Fund – More than $1.5 million in funding available yearly to Emory and Georgia Tech innovations through a multi-stage, competitive application process.

Biolocity Launch – Active project management and formal coordination with the life-sciences commercialization ecosystem for Biolocity Fund awardees.


 

By The Numbers


Program History

Project Portfolio

Biolocity News

Schedule a Consultation

Page 1 of 27

Powered by WordPress & Theme by Anders Norén